Sodium-glucose cotransporter 2 inhibitor in heart failure patients and their outcomes: A meta-analysis of randomized controlled trials

Figure 1 PRISMA flow diagram for selection criteria and search characteristics. RCT: Randomized controlled trials.

Figure 2 Statistical analysis and forest plots in randomized controlled trials. A: The risk ratio for hospitalization for heart failure in patients receiving a Sodium-Glucose cotransporter 2 inhibitor vs placebo; B: The odds ratio for cardiovascular deaths in patients receiving Sodium-glucose cotransporter 2 inhibitor vs placebo; C: The odds ratio for all-cause mortality in patients receiving a Sodium-Glucose cotransporter 2 inhibitor vs placebo. Squares represent individual study estimates, sized by study weight; horizontal lines show 95%CI. The diamond denotes the pooled effect estimate and its 95%CI. SGLT2: Sodium-glucose cotransporter 2.